期刊文献+

中毒性表皮坏死松解型药疹治疗研究进展 被引量:7

下载PDF
导出
摘要 中毒性表皮坏死松解型(toxicepidermalnecrolysis,TEN)药疹,1956年由Lyellut首先报道,又称Lyellat综合征,是发生于皮肤黏膜的严重的药物不良反应,病情发展迅速,发病率低,为全球0.4/100万~1.2/100万,平均病死率为25%。35%㈨。TEN的治疗近年来取得了一些进展,现综述如下。
作者 祝伦 蒋法兴
出处 《安徽医学》 2013年第11期1714-1717,共4页 Anhui Medical Journal
  • 相关文献

参考文献32

  • 1Trent J, Haleru M, French LE, et al. Toxic epidermal necrolysis and intravenous immunoglobulin: a review [ J ]. Semin Cutan Med Surg, 2006,25(2) :91 -93.
  • 2Tartarone A, Lerose R. Stevens -johnson syndrome and tox- ic epidermal necrolysis: what do we know [ J] ? Ther Drug Monit,2010,32 (6) :669 - 672.
  • 3Paquet P, Pierard GE. New insights in toxic epidermal necrolysis ( Lyell's syndrome) [ J ]. Drug Saf, 2010,33 (3) :189 -212.
  • 4Endorf FW , Cancio LC , Gibran NS . Toxic epidermal necrolysis clinical guidelines [ J ]. J Burn Care Res, 2008 (5) :706 -712.
  • 5Evans J. Topical treatment protocol for stevens -Johnson sand toxic epidermal necrolysis[ J ]. J Wound Ostomy Con- tinence Nurs,2009 ,36(5) :509 - 511.
  • 6Shay E, Kheirkhah A, Liang L, et al. Amniotic membrane transplantation as a new therapy for the acute ocular mani- festations of Stevens - Johnson syndrome and toxic epider- mal necrolysis [ J ]. Surv Ophthalmol, 2009,54 ( 6 ) : 686 - 696.
  • 7See S, Mumford JM. Trimethopfim/sulfamethoxazole - induced toxic epidermal necrolysis [ J ]. Ann Pharmacother, 2001,35 (6) :694 - 697.
  • 8Wolf R, Davidovici B. Severe cutaneous adverse drug reactions: who should treat, where and how? Facts and contro- versies [ J ]. Clin Dermatol, 2010,28 ( 3 ) : 344 - 348.
  • 9Engelhardt SL, Schurr MJ, Helgerson RB. Toxic epidermal necrolysis:an analysis of referral patterns and steroid usage [J]. J Burn Care Rehabil,1997,18(6) :520-524.
  • 10Trautmann A, Akdis M, Schmid - Grendelmeier P. Targe- ting keratinocyte apoptosis in the treatment of atopic dermati- tis and allergic contact dermatitis [ J ]. J Allergy Clin Immunol, 2001,108 (5) : 839 - 846.

二级参考文献27

  • 1French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int, 2006, 55( 1 ): 9-16.
  • 2Paquet P, Pierard GE, Quatresooz P. Novel treatments for druginduced toxic epidermal necrolysis (Lyell's syndrome ). hat Arch Allergy Immunol, 2005, 136(3 ): 205-216.
  • 3Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol, 2000, 115(2): 149-153.
  • 4Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science, 1998, 282(5388): 490-493.
  • 5Stella M, Clemente A, Bollero D, et al. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Bums, 2007, 33(4): 452-459.
  • 6Nassif A,Moslehi H,Le Gouvello S,et al.Evaluation of the potential role of cytokines in toxic epidermal necrolysis[J].J Invest Dermatol,2004,123(5):850-855.
  • 7Nassif A,Beusnssan A,Boumsell L,et al.Toxic epidermal necrolysis:effector cells are drag-specific cytotoxic T cells[J].J Allergy Clin Immunol,2004,114(5):1209-1215.
  • 8Correia O,Delgado L,Barbosa IL,et al.Increased interleukin 10,tumor necrosis factor alpha,and interleukin 6 levels in blister fluid of toxic epidermal necrolysis[J].J Am Acad Dermatol,2002,47(1):58-62.
  • 9Caproni M,Torchia D,Schincaglia E,et al,Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis[J].Br J Dermatol,2006,155(4):722-728.
  • 10Imai T,Yoshida T,Baba M,et al.Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector[J].J Biol Chem,1996,271(35):21514-21521.

共引文献35

同被引文献62

  • 1艾哈迈德,郑捷.药疹发病机理研究的几个热点[J].实用皮肤病学杂志,2009,2(3):149-152. 被引量:10
  • 2Paul C,Wolkenstein P,Adle H,et al.Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis[J].Br J Dermatol,1996,134(4):710-714.
  • 3Bachot N,Revuz J,Roujeau JC.Intravenous immunoglobulin treatment for Stevens Johnson syndrome and toxic epidermal necrolysis:a prospective noncomparative study showing no benefit on mortality or progression[J].Arch Dermatol,2003,139(1):33-36.
  • 4王一枫,阎永宁.大疱性表皮坏死松解型药疹31例临床分析[J].浙江医学,2007,29(12):1294-1295. 被引量:8
  • 5Digwood-Lettieri S, Reilly KJ, Haith LR Jr, et al. Levofloxacin- induced toxic epidermal neerolysis in an elderly patient[J]. Pharmacotherapy, 2002, 22(6): 789-793.
  • 6Islam AF, Rahman MS. Levofloxacin-induced fatal toxic epidermal necrolysis[J]. Ann Pharmacother, 2005, 39(6): 1136-1137.
  • 7Christie MJ, Wong K, Ting RH, et al. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure[J]. Ann Pharmacother, 2005, 39(5): 953-955.
  • 8Davila G, Ruiz-Hornillos J, Rojas P, et al. Toxic epidermal necrolysis induced by levofloxacin[J]. Ann Allergy Asthma Immunol, 2009, 102(5): 441-442.
  • 9Teo WL, Pang SM. Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immurtoglobulin[J]. Ann Acad Med Singapore, 2010, 39(8): 660-661.
  • 10Fernandez Arenas O, Lopez Lunar E, Gutierrez Garcia M, et al. Levofloxacin-related Stevens-Johnson syndrome[J]. Farm Hosp, 2012, 36(1): 53-55.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部